Are changes in olanzapine-induced liver enzyme levels associated with GSTT1, GSTM1, GSTP1, and OGG1 gene polymorphisms?
By: Aylin Elkama, Nazlıcan İlik, Mehmet Ak and Bensu Karahalil
Authors
Aylin Elkama
Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey
Nazlıcan İlik
Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey
Mehmet Ak
Necmettin Erbakan University, Meram Faculty of Medicine, Department of Psychiatry, Konya, Turkey
Gazi University Faculty of Pharmacy, Department of Toxicology, Ankara, Turkey
Eastern Mediterranean University Faculty of Pharmacy, Department of Toxicology, Famagusta, North Cyprus
Language: English, Croatian, Slovenian
Page range: 61 - 67
Submitted on: Aug 1, 2023
Accepted on: Feb 1, 2024
Published on: Mar 29, 2024
Published by: Institute for Medical Research and Occupational Health
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2024 Aylin Elkama, Nazlıcan İlik, Mehmet Ak, Bensu Karahalil, published by Institute for Medical Research and Occupational Health
This work is licensed under the Creative Commons Attribution 4.0 License.